First Report of the Durability of the Antibody Response in Maintenance Hemodialysis Patients and Kidney Transplant Recipients Vaccinated with Two Doses of the ChAdOx1 nCoV-19 Vaccine: A Prospective, Comparative, Multicenter, Observational Study. — SciRadar